International Transaction Journal of Engineering, Management, & Applied Sciences & Technologies


:: International Transaction Journal of Engineering, Management, & Applied Sciences & Technologies

ISSN 2228-9860
eISSN 1906-9642



  • Investigating the Effects of Endocrine-Disrupting Chemicals/Toxicants on the Human Ovary & Its Inflammatory Signalling Pathways

    Feras Sulaiman Aljizani, Fahad Eidah Al Thubaiti, Faisal Ali Althobyani, Abdullkareem Alamri (King Fahad Armed Forces Hospital. SAUDI ARABIA).

    Discipline: Endocrinology.

    ➤ FullText

    doi: 10.14456/ITJEMAST.2022.234

    Keywords:Endocrine-Disrupting Chemicals (EDCs); Ovary; Polycystic Ovary Syndrome (PCOS); Ovarian Cancer (OC); Ovarian dysfunction; Inflammatory signalling pathways

    The ovary is a vital organ susceptible to various illnesses when disrupted. Concerns have been raised about the effect of endocrine-disrupting chemicals (EDCs) on the reproductive organs, especially the ovaries. EDCs, mainly synthetic, can be present in copious amounts in the environment, contributing to daily human exposure. Studies have established a positive correlation between these chemicals and abnormal reproductive functioning. Ovary functions are undertaken through inflammatory signalling pathways - e.g. cytokines; CRP; ROS; and COX-2 - which in turn alter the functionality of the organ. This study investigates the effect of EDCs on the human ovary through these inflammatory signalling pathways and determines the consequential ovarian dysfunctions. A literature review was to search the EMBASE and MEDLINE databases for in-depth studies of EDCs exposure & subsequent ovarian inflammasome effects. It revealed the precise role of the effective process of EDCs on ovarian inflammatory mediators is complicated. Experimental evidence demonstrated the ability of EDCs (e.g. BPA, HPTE, β-HCH, DDE, PBDEs, PCBs, PFASs, Phthalates) to survive in the female ovary and its component cells through the blood-follicle barrier. Further, studies presented evidence of the association between EDCs exposure and some ovarian dysfunction conditions like ovarian cancer (OC), polycystic ovarian syndrome (PCOS) and cell ageing due to its impact on the endpoint of the ovaries through the inflammation pathways specifically cytokines (TNF-α, ILs and NF-kB), CXCL12, ROS, OS and COX-2. Many studies assumed a higher concentrated level of EDCs exposure with adverse ovarian inflammatory effects. However, these studies did not provide adequate or conclusive evidence that ovarian disruptions through the inflammatory mediators are triggered solely by EDCs exposure. Further experimental studies that test different levels of exposure in the general human population are needed to better understand the possible risks of EDCs on the role of ovarian inflammation.

    Paper ID: 13A12C

    Cite this article:

    Aljizani, F.S., Thubaiti, F.E.A., Althobyani, F.A., Alamri A. (2022). Investigating the Effects of Endocrine-Disrupting Chemicals/Toxicants on the Human Ovary & Its Inflammatory Signalling Pathways. International Transaction Journal of Engineering, Management, & Applied Sciences & Technologies, 13(12), 13A12C, 1-17. http://TUENGR.COM/V13/13A12C.pdf DOI: 10.14456/ITJEMAST.2022.234


  1. Agarwal, A., Gupta, S. & Sharma, R. K. (2005) 'Role of oxidative stress in female reproduction', Reproductive Biology and Endocrinology, 3, p. 28.
  2. Akgul, S., Sur, u., Duzceker, Y., Balci, A., Kizilkan, M. P., Kanbur, N., Bozdag, G., Erkekoglu, P., Gumus, E. & Kocer-Gumusel, B. (2019) 'Bisphenol A and phthalate levels in adolescents with polycystic ovary syndrome', Gynaecological Endocrinology, 35, pp. 1084-1087.
  3. Balaguer, P., Delfosse, V., Grimaldi, M. & Bourguet, W. (2017) 'Structural and functional evidence for the interactions between nuclear hormone receptors and endocrine disruptors at low doses', Comptes Rendus Biologies, 340, pp. 414-420.
  4. Barrett, E. S. & Sobolewski, M. (2014) 'Polycystic ovary syndrome: do endocrine disrupting chemicals play a role?', Seminars in Reproductive Medicine, 32, 3, p. 166.
  5. Bhattacharya, P. & Keating, A. F. (2012) 'Impact of environmental exposures on ovarian function and the role of xenobiotic metabolism during over toxicity', Toxicology and Applied Pharmacology, 261, pp. 227-235.
  6. BioNinja, 2020. [image] Available at: (Accessed 30 August 2020).
  7. Boots, C. E. & Jungheim, E. S. (2015) 'Inflammation and human ovarian follicular dynamics', Seminars in Reproductive Medicine, 33, 4, pp. 270-275.
  8. Campbell, M. & Jialal, I. (2019) 'Physiology, endocrine hormones', in StatPearls. Treasure Island (FL): StatPearls Publishing. Available at: (Accessed 17 July 2020).
  9. Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X. & Zhao, L. (2018) 'Inflammatory responses and inflammation-associated diseases in organs', Oncotarget, 9, p. 7204.
  10. Clancy, K. B., Baerwald, A. R. & Pierson, R. A. (2013) 'Systemic inflammation is associated with ovarian follicular dynamics during the human menstrual cycle', PloS One, 8(5), e64807.
  11. Colquitt P. J. (1995) 'The effect of occupational exposure to mercury vapour on the fertility of female dental assistants', Occupational and Environmental Medicine, 52, 3, p. 214.
  12. Connolly, L. (2009) 'Endocrine-disrupting chemicals: origins, fates and transmission into the food chain', in Endocrine-disrupting chemicals in food. Elsevier.
  13. Craig, Z. R., Wang, W. & Flaws, J. A. (2011) 'Endocrine-disrupting chemicals in ovarian function: effects on steroidogenesis, metabolism and nuclear receptor signalling', Reproduction, 142, p. 633.
  14. Diamanti-Kandarakis, E. & Dunaif, A. (2012) 'Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications', Endocrine Reviews, 33, pp. 981-1030.
  15. Dietert, R. R. (2012) 'Misregulated inflammation as an outcome of early-life exposure to endocrine-disrupting chemicals', Reviews on Environmental Health, 27, pp. 117-131.
  16. Ding, N., Harlow, S. D., Randolph, J. F., Loch-Caruso, R. & Park, S. K. (2020) 'Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary', Human Reproduction Update. Available at: (Accessed 3 July 2020).
  17. Duursen, M., Boberg, J., Christiansen, S., Connolly, L., Damdimopoulou, P., Filis, P., Fowler, P. A., Gadella, B. M., Holte, J. & Jaager, K. (2020) 'Safeguarding female reproductive health against endocrine disrupting chemicals-the FREIA project', International Journal of Molecular Sciences, 21, p. 3215.
  18. Fang, L., Chang, H.-M., Cheng, J.-C., Leung, P. C. & Sun, Y.-P. (2015) 'Nitric oxide and cGMP induce COX-2 expression and PGE2 production in human granulosa cells through the CREB signalling pathway', The Journal of Clinical Endocrinology & Metabolism, 100, pp. E262-E269.
  19. Ferguson, K. K., Cantonwine, D. E., Mcelrath, T. F., Mukherjee, B. & Meeker, J. D. (2016) 'Repeated measures analysis of associations between urinary bisphenol-A concentrations and biomarkers of inflammation and oxidative stress in pregnancy', Reproductive Toxicology, 66, pp. 93-98.
  20. FREIA Project (2020) Discovering new insights. Available at: (Accessed 7 July 2020).
  21. Gore, A. C., Chappell, V., Fenton, S., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J. & Zoeller, R. (2015) 'EDC-2: the Endocrine Society's second scientific statement on endocrine-disrupting chemicals', Endocrine Reviews, 36, pp. E1-E150.
  22. Grindler, N. M., Allsworth, J. E., Macones, G. A., Kannan, K., Roehl, K. A. & Cooper, A. R. (2015) 'Persistent organic pollutants and early menopause in US women', PloS One, 10, p. e0116057.
  23. Hall, J. M. & Korach, K. S. (2013) 'Endocrine-disrupting chemicals promote the growth of ovarian cancer cells via the ER-CXCL12-CXCR4 signalling axis', Molecular Carcinogenesis, 52, pp. 715-725.
  24. Hoyer, P. B. (2013) Ovarian toxicology. Boca Raton-London-New York, CRC Press.
  25. Huang, M., Liu, S., Fu, L., Jiang, X. & Yang, M. (2020) 'Bisphenol A and its analogues bisphenol S, bisphenol F and bisphenol AF, induce oxidative stress and biomacromolecular damage in human granulosa KGN cells', Chemosphere. Available at: (Accessed 22 August 2020).
  26. Jacobs, M. N., Marczylo, E. L., Guerrero-Bosagna, C. & Ruegg, J. (2017) 'Marked for life: epigenetic effects of endocrine-disrupting chemicals', Annual Review of Environment and Resources, 42, pp. 105-160.
  27. Kelley, A. S., Banker, M., Goodrich, J. M., Dolinoy, D. C., Burant, C., Domino, S. E., Smith, Y. R., Song, P. X. & Padmanabhan, V. (2019) 'Early pregnancy exposure to endocrine-disrupting chemical mixtures are associated with inflammatory changes in maternal and neonatal circulation', Scientific Reports, 9, pp. 1-14.
  28. Kahn, L. G., Philippat, C., Nakayama, S. F., Slama, R., & Trasande, L. (2020) 'Endocrine-disrupting chemicals: implications for human health', The Lancet Diabetes & Endocrinology, 8(8), pp. 703-718.?
  29. Kulbe, H., Thompson, R., Wilson, J. L., Robinson, S., Hagemann, T., Fatah, R., Gould, D., Ayhan, A. & Balkwill, F. (2007) 'The inflammatory cytokine tumour necrosis factor-? generates an autocrine tumour-promoting network in epithelial ovarian cancer cells', Cancer Research, 67, pp. 585-592.
  30. La Merrill, M. A., Vandenberg, L. N., Smith, M. T., Goodson, W., Browne, P., Patisaul L, H. B., Guyton, K. Z., Kortenkamp, A., Cogliano, V. J. & Woodruff, T. J. (2019) 'Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification'. Nature Reviews Endocrinology, pp. 1-13.
  31. La Perle, K. & Dintzis, S. (2018) 'Endocrine system', in Comparative Anatomy and Histology. Academic Press, pp. 251-273.
  32. Lumen Learning (2020) The ovarian cycle, the menstrual cycle, and menopause. Available at: (Accessed 13 August 2020).
  33. Muralidhar, G. G. & Barbolina, M. V. (2014) 'Chemokine receptors in epithelial ovarian cancer', International Journal of Molecular Sciences, 15, pp. 361-376.
  34. National Institute of Environmental Health Sciences (2020) Endocrine disruptors. Available at: index.cfm (Accessed 1 July 2020).
  35. Neel, B. A. & Sargis, R. M. (2011) 'The paradox of progress: environmental disruption of metabolism and the diabetes epidemic', Diabetes, 60, pp. 1838-1848.
  36. Ness, R. B., Grisso, J. A., Cottreau, C., Klapper, J., Vergona, R., Wheeler, J. E., Morgan, M. & Schlesselman, J. J. (2000) 'Factors related to inflammation of the ovarian epithelium and risk of ovarian cancer', Epidemiology, 11, pp. 111-117.
  37. Palioura, E. & Diamanti-Kandarakis, E. (2015) 'Polycystic ovary syndrome (PCOS) and endocrine-disrupting chemicals (EDCs)', Reviews in Endocrine and Metabolic Disorders, 16, pp. 365-371.
  38. Pasqualotto, E. B., Agarwal, A., Sharma, R. K., Izzo, V. M., Pinotti, J. A., Joshi, N. J. & Rose, B. I. (2004) 'Effect of oxidative stress in follicular fluid on the outcome of assisted reproductive procedures', Fertility and Sterility, 81, pp. 973-976.
  39. Patel, S., Zhou, C., Rattan, S. & Flaws, J. A. (2015) 'Effects of endocrine-disrupting chemicals on the ovary', Biology of Reproduction, 93(20), pp. 1-9.
  40. Petroff, B. K., Roby, K. F., Gao, X., Son, D.-S., Williams, S., Johnson, D., Rozman, K. K. & Terranova, P. F. (2001) 'A review of mechanisms controlling ovulation with implications for the anovulatory effects of polychlorinated dibenzo-p-dioxins in rodents', Toxicology, 158, pp. 91-107.
  41. Piazza, M. J. & Urbanetz, A. A. (2019) 'Environmental toxins and the impact of other endocrine-disrupting chemicals in women's reproductive health', JABRA Assisted Reproduction, 23, p. 154.
  42. Popple, A., Durrant, L., Spendlove, I., Rolland, P., Scott, I., Deen, S. & Ramage, J. (2012) 'The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer', British Journal of Cancer, 106, pp. 1306-1313.
  43. Ptak, A., Hoffmann, M., Gruca, I. & Bar?, J. (2014) 'Bisphenol A induce ovarian cancer cell migration via the MAPK and PI3K/Akt signalling pathways', Toxicology Letters, 229, pp. 357-365.
  44. Racho?, D. (2015) 'Endocrine-disrupting chemicals (EDCs) and female cancer: informing the patients', Reviews in Endocrine and Metabolic Disorders, 16, pp. 359-364.
  45. Rattan, S., Zhou, C., Chiang, C., Mahalingam, S., Brehm, E. & Flaws, J. A. (2017) 'Exposure to endocrine disruptors during adulthood: consequences for female fertility', Journal of Endocrinology, 233, pp. R109-R129.
  46. Ravichandran, G., Lakshmanan, D. K., Raju, K., Elangovan, A., Nambirajan, G., Devanesan, A. A. & Thilagar, S. (2019) 'Food advanced glycation end products as potential endocrine disruptors: an emerging threat to contemporary and future generation', Environment International, 123, pp. 486-500.
  47. Richards, J. S. (2018) 'The ovarian cycle', in Vitamins and hormones. Academic Press, 107, pp. 1-25.
  48. Richards, J. S. & Pangas, S. A. (2010) 'The ovary: basic biology and clinical implications', The Journal of Clinical Investigation, 120, pp. 963-972.
  49. Romani, F., Tropea, A., Scarinci, E., Russo, C. D., Lisi, L., Catino, S., Lanzone, A. & Apa, R. (2013) 'Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function', Journal of Environmental Science and Health, Part C, 31, pp. 170-180.
  50. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Working Group (2004) 'Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome', Fertility and Sterility, 81, pp. 19-25.
  51. Rutkowska, A. & Racho?, D. (2014) 'Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS)', Gynaecological Endocrinology, 30, pp. 260-265.
  52. Samtani, R., Sharma, N. & Garg, D. (2018) 'Effects of endocrine-disrupting chemicals and epigenetic modifications in ovarian cancer: a review', Reproductive Sciences, 25, pp. 7-18.
  53. Savant, S. S., Sriramkumar, S. & O'Hagan, H. M. (2018) 'The role of inflammation and inflammatory mediators in the development, progression, metastasis, and chemoresistance of epithelial ovarian cancer', Cancers, 10, p. 251.
  54. Shah, H. K., Sharma, T. & Banerjee, B. D. (2020) 'Organochlorine pesticides induce inflammation, ROS production, and DNA damage in human epithelial ovary cells: an in vitro study', Chemosphere, 246, 125691.
  55. Silbergeld, E. K. & Flaws, J. A. (2002) 'Environmental exposures and women's health', Clinical Obstetrics and Gynaecology, 45, pp. 1119-1128.
  56. Soave, I., Occhiali, T., Assorgi, C., Marci, R. & Caserta, D. (2020) 'Environmental toxin exposure in polycystic ovary syndrome women and possible ovarian neoplastic repercussion', Current Medical Research and Opinion, 36, pp. 693-703.
  57. Vannuccini, S., Clifton, V. L., Fraser, I. S., Taylor, H. S., Critchley, H., Giudice, L. C. & Petraglia, F. (2016) 'Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome', Human Reproduction Update, 22, pp. 104-115.
  58. Wander, K., Brindle, E. & O'Connor, K. A. (2008) 'C-reactive protein across the menstrual cycle', American Journal of Physical Anthropology, 136, pp. 138-146.
  59. Wang, H. S., Sthiannopkao, S., Du, J., Chen, Z. J., Kim, K. W., Yasin, M. S. M., Jamal, H. H., Wong, K-C. C. & Wong, M. H. (2011) 'Daily intake and human risk assessment of organochlorine pesticides (OCPs) based on Cambodian market basket data', Journal of hazardous materials, 192(3), pp. 1441-1449.?
  60. Yang, O., Kim, H. L., Weon, J.-I. & Seo, Y. R. (2015) 'Endocrine-disrupting chemicals: a review of toxicological mechanisms using molecular pathway analysis', Journal of Cancer Prevention, 20, p. 12.
  61. Zhang, J.-M. & An, J. (2007) 'Cytokines, inflammation and pain', International Anesthesiology Clinics, 45, p. 27.
  62. Zota, A. R., Geller, R. J., Romano, L. E., Coleman-Phox, K., Adler, N. E., Parry, E., Wang, M., Park, J.-S., Elmi, A. F. & Laraia, B. A. (2018) 'Association between persistent endocrine-disrupting chemicals (PBDEs, OH-PBDEs, PCBs, and PFASs) and biomarkers of inflammation and cellular ageing during pregnancy and postpartum', Environment International, 115, pp. 9-20.

Other issues:


Call-for-Scientific Papers
Call-for-Research Papers:
ITJEMAST invites you to submit high quality papers for full peer-review and possible publication in areas pertaining engineering, science, management and technology, especially interdisciplinary/cross-disciplinary/multidisciplinary subjects.

To publish your work in the next available issue, your manuscripts together with copyright transfer document signed by all authors can be submitted via email to Editor @ (please see all detail from Instructions for Authors)

Publication and peer-reviewed process:
After the peer-review process, articles will be on-line published in the available next issue. However, the International Transaction Journal of Engineering, Management, & Applied Sciences & Technologies cannot guarantee the exact publication time as the process may take longer time, subject to peer-review approval and adjustment of the submitted articles.